Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity in chronic lymphocytic leukemia.

J H Ward1

  • 1Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, 2000 Circle of Hope, Suite 2100, Salt Lake City, UT 84112-5550, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary

Chronic lymphocytic leukemia (CLL) can trigger immune disorders like anemia and thrombocytopenia. Treatment involves corticosteroids, splenectomy, or CLL-targeted therapies, with immunosuppression for pure red cell aplasia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.

Annals of the Royal College of Surgeons of England·2014
Same author

The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs).

British journal of cancer·2013
Same author

Hospitals.

Journal of the National Medical Association·2010
Same author

U. S. Veterans' Hospital.

Journal of the National Medical Association·2010
Same author

Application of hologram techniques for particle size analysis.

Applied optics·2010
Same author

Recurrent epistaxis as a presenting sign of androgen-sensitive metastatic prostate cancer.

Singapore medical journal·2009

Area of Science:

  • Hematology
  • Immunology

Background:

  • Chronic lymphocytic leukemia (CLL) is frequently associated with immune-mediated complications.
  • Autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) are common manifestations in CLL patients.

Purpose of the Study:

  • To outline management strategies for AIHA and ITP in the context of CLL.
  • To discuss treatment options for pure red cell aplasia (PRCA) in CLL.

Main Methods:

  • Review of clinical management approaches for CLL-associated cytopenias.
  • Discussion of therapeutic interventions including corticosteroids, splenectomy, and CLL-directed therapies.
  • Consideration of immunosuppressive therapy for PRCA.

Main Results:

  • Corticosteroids are effective initial therapy for AIHA and ITP in CLL.

Related Experiment Videos

  • Splenectomy is a viable option for refractory cases.
  • Treatment of underlying CLL may be necessary for persistent cytopenias, but caution is advised with purine analogs due to potential precipitation of AIHA.
  • Immunosuppressive therapy is generally effective for PRCA in CLL.

    • Conclusions:

    • Management of immune cytopenias in CLL requires a stepwise approach.
    • Treatment decisions should consider the specific cytopenia, response to initial therapies, and the status of the underlying CLL.
    • PRCA in CLL typically responds to immunosuppression.